Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_114684612 Show fit | 0.40 |
ENST00000533213.6
ENST00000369252.8 |
actin binding LIM protein 1 |
|
chr10_-_114684457 Show fit | 0.39 |
ENST00000392955.7
|
actin binding LIM protein 1 |
|
chr1_+_160400543 Show fit | 0.36 |
ENST00000368061.3
|
VANGL planar cell polarity protein 2 |
|
chr2_-_70553440 Show fit | 0.26 |
ENST00000450929.5
|
transforming growth factor alpha |
|
chr5_-_135578983 Show fit | 0.22 |
ENST00000512158.6
|
C-X-C motif chemokine ligand 14 |
|
chr6_-_25874212 Show fit | 0.16 |
ENST00000361703.10
ENST00000397060.8 |
solute carrier family 17 member 3 |
|
chr12_-_89352487 Show fit | 0.15 |
ENST00000548755.1
ENST00000279488.8 |
dual specificity phosphatase 6 |
|
chr8_+_49911801 Show fit | 0.15 |
ENST00000643809.1
|
syntrophin gamma 1 |
|
chr12_-_89352395 Show fit | 0.14 |
ENST00000308385.6
|
dual specificity phosphatase 6 |
|
chr6_+_130018565 Show fit | 0.13 |
ENST00000361794.7
ENST00000526087.5 ENST00000533560.5 |
L3MBTL histone methyl-lysine binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.1 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0043017 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |